Medial Patellofemoral Ligament Reconstruction With or Without Lateral Retinaculum Release

Episodic Patellar Dislocation Clinical Trial

Official title:

Randomized Control Trial on Lateral Retinaculum Release in MPFL Reconstruction

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01719666
• Other study ID #: 2010.651
• Status: Active, not recruiting
• Phase: N/A
• Start date: November 22, 2011
• Est. completion date: November 2024

Study information

• Verified date: March 2023
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators hypothesis is lateral retinaculum release has no effect on treatment of Patellar Recurrent Dislocation with Medial Patellofemoral Ligament (MPFL) reconstruction.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 140
• Est. completion date: November 2024
• Est. primary completion date: November 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• age between 18yo and 45yo

• indication for MPFL reconstruction

• unilateral or bilateral indication

Exclusion Criteria:

• indication for bony procedures

• previous surgery for PF disorders

• patient refusal

Related Conditions & MeSH terms

• Episodic Patellar Dislocation
• Patellar Dislocation

Intervention

Procedure:
• MPFL reconstruction and lateral retinaculum release
MPFL is performed with a standard technique using gracilis tendon. A tunnel is performed at the femoral part with a bioabsorbable screw fixation and 2 bundles with suture fixation at the patellar side
• conventional surgery
conventional surgery: MPFL reconstruction

Locations

Country	Name	City	State
France	Croix-Rousse Hospital, Hospices Civils de Lyon	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patellar tilt measurement	IKDC score, patellar tilt measurement on x-rays and CT-scan	2 years of follow up
Secondary	rate of complications		2 years of follow up